United States and China Launch Public-Private Partnership on Healthcare – Increasing collaboration in the healthcare sector
On the occasion of the State Visit of President Hu Jintao to the United States, the U.S. Trade and Development Agency (USTDA), the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Commerce (Commerce) joined with China’s Ministries of Health (MoH) and Commerce (MOFCOM) to announce their support for the establishment a new public-private partnership in the healthcare sector.
Initially, twelve U.S. companies and six supporting organizations will participate in this partnership, alongside the supporting U.S. and Chinese Government agencies. The partnership will be organized around U.S. healthcare industry strengths and government capabilities in order to foster long-term cooperation with China in the areas of research, training, regulation and the adoption of an environment that will increase accessibility to healthcare services in China. Participating U.S. companies initially include 3M, Abbott, Chindex, Cisco, General Electric, IBM, Intel, Johnson & Johnson, Medtronic, Microsoft, Motorola, and Pfizer. Supporting organizations include AdvaMed, the Alliance for Healthcare Competitiveness, the American Chamber of Commerce in China, the American Chamber of Commerce in Shanghai, PhRMA and the U.S.-China Business Council.
rest